Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,622.00
Bid: 2,622.00
Ask: 2,624.00
Change: -14.00 (-0.53%)
Spread: 2.00 (0.076%)
Open: 2,640.00
High: 2,644.00
Low: 2,620.00
Prev. Close: 2,636.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Coca-Cola HBC Investor Day

25 May 2023 07:00

RNS Number : 6362A
Coca-Cola HBC AG
25 May 2023
 

FOR IMMEDIATE RELEASE

 

Coca-Cola HBC AG Investor Day 25 May 2023

 

 

ACCELERATING THE DELIVERY OF SUSTAINABLE AND PROFITABLE GROWTH

 

Zug, Switzerland - 25 May 2023 - Coca-Cola HBC AG ("Coca-Cola HBC", "Company", "we'), a growth-focused Consumer Packaged Goods business and strategic bottling partner of The Coca-Cola Company, is today hosting an investor event in Rome, Italy. Alongside an opportunity to meet and hear from various members of the senior management team, the event includes an update on the Company's growth strategy and financial targets, extended to cover the medium-term, with an increased revenue growth target.

 

The updates presented today build on the growth plans and targets set out at the Company's last investor day in 2019. Since then, Coca-Cola HBC has refocused resources to strengthen core growth capabilities and managed through various periods of macro-instability to deliver a strong recovery in growth and material improvement to overall profit.

 

Coca-Cola HBC will set out the progress it has made across its five growth strategy pillars, which remain unchanged, and how these are positioning the Company for higher levels of growth over the medium term. This includes how we are prioritising the best opportunities in our unique, 24/7 sparkling-led beverage portfolio, and how our investment in new digital and data-enhanced tools strengthens our route-to-market approach and best-in-class execution.

 

As part of the evolution of our growth story, we are updating our financial targets to cover the medium-term period beyond 2023. Alongside continued strong execution of our strategy, these targets reflect a positive outlook for our market categories and our expectation to gain further market share. As a result, our targets are:

 

· Average annual organic revenue growth of 6-7% (previously a target of 5-6% per annum)

· Average annual organic EBIT margin expansion of 20-40 basis points per annum

· Capital expenditure as a percentage of revenue in the range of 6.5-7.5% per annum

· Continued focus on growing ROIC (2022: 14.1%)

 

We reaffirm our commitment to a progressive dividend representing a pay-out ratio of between 40-50% of comparable Earnings Per Share per annum. This will be well supported by our delivery of growth in free cash flow in the mid-term to support our capital allocation priorities. Our target of maintaining a ratio of net debt to EBITDA in the range 1.5 to 2 times is also unchanged.

We remain confident that we will achieve the guidance for 2023, as set out at our Q1 trading update on 3 May 2023. This included organic revenue growth above our 5-6% average growth target and organic EBIT growth at the top end of our -3% to +3% range for the year.

Zoran Bogdanovic, Chief Executive Officer of Coca-Cola HBC AG, commented:

"Our announcement today builds on the successful ongoing implementation of our strategy, and the strong performance we have achieved over the four years since our last investor day.

Despite the recent challenges of COVID, strong commodity inflation and the conflict in Ukraine, we continue to make significant investments in the business to transform our capabilities and seize growth opportunities. This is particularly true in respect of the application of digital tools and data, together with the strong brands we sell and our geographic reach. These targeted initiatives further strengthen our customer and consumer offering across key channels, reinforcing our ambitions for growth.

The combination of excellent people, with strong capabilities, together with a diverse footprint and a unique, broad portfolio of products, set us up well to win greater share in growing markets. We look forward to delivering further strong growth as we make progress towards our vision of being The Leading 24/7 Beverage Partner."

The full agenda of our Investor Day includes:

- An introduction by Anastassis G. David, Chairman, Coca-Cola HBC

- Keynote presentations by Zoran Bogdanovic (CEO), Naya Kalogeraki (COO) and Ben Almanzar (CFO) of Coca-Cola HBC

- Guest presentation by Manolo Arroyo (CMO of The Coca-Cola Company)

- Further presentations and workshops, covering the development of Adult Sparkling, Coffee, Data, Insights & Analytics, and Digital, led by members of the Coca-Cola HBC team

- A panel discussion between Zoran Bogdanovic, Naya Kalogeraki, and guest Nikos Koumettis, President Europe of the Coca-Cola Company

- A market visit led by members of the Coca-Cola HBC Italian team

All the plenary presentations and question and answer sessions will be broadcast live during the day and will be made available subsequently for further viewing. Overviews of the four workshops held during the day will also be made available.

There will be opportunities for online participants to ask questions. Please register to view the webcast and participate in the Q&A on the investor relations website.

For any questions, please contact a member of the investor relations team, contact details are below.

 

 

 

 

 

 

 

 

 

 

 

 

Enquiries

Coca‑Cola HBC Group

Investor and Analysts:

John Dawson 

Head of Investor Relations

Tel: +44 7522 619509

 john.dawson@cchellenic.com

 

Jemima Benstead

Investor Relations Manager

Tel: +44 7740 535130

jemima.benstead@cchellenic.com

 

Marios Matar

Investor Relations Manager

Tel: +30 697 444 3335

marios.matar@cchellenic.com

 

Virginia Phillips

Investor Relations Manager

 

Tel: +44 (0) 7864 686582

virginia.phillips@cchellenic.com

 

 

Media:

 

Sonia Bastian

Head of Communications

Tel: +41 7946 88054

sonia.bastian@cchellenic.com

 

 

Ciara Cashen

Senior Group Communications Manager

 +353 861940885

ciara.cashen@cchellenic.com

 

 

 

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We create value for all our stakeholders by supporting the socio-economic development of the communities in which we operate, and we believe building a more positive environmental impact is integral to our future growth. Together, we and our customers serve 715 million consumers across a broad geographic footprint of 29 countries on three continents. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, offering consumer-leading beverage brands in the sparkling, juice, water, sport, energy, plant-based, ready-to-drink tea, coffee, adult sparkling and premium spirits categories. These beverages include Coca-Cola, Coca-Cola Zero, Schweppes, Kinley, Costa Coffee, Valser, Römerquelle, Fanta, Sprite, Powerade, FuzeTea, Dobry, Cappy, Monster and Adez. We foster an open and inclusive work environment amongst our 33,000 employees and we are ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and is listed on the Athens Exchange (ATHEX: EEE). For more information, please visit https://www.coca-colahellenic.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDNKPBNPBKKAPB
Date   Source Headline
3rd May 202412:46 pmRNSDirector/PDMR Shareholding
3rd May 202412:38 pmRNSDirector/PDMR Shareholding
2nd May 20245:41 pmRNSTransaction in Own Shares
2nd May 202412:40 pmRNSAthens Exchange trading date of ordinary shares
1st May 20245:47 pmRNSTransaction in Own Shares
1st May 202410:09 amRNSBlock listing Interim Review
1st May 20249:10 amRNSIssue of equity and total voting rights
30th Apr 20247:00 amRNSStrong start; reiterating 2024 guidance
19th Apr 20249:20 amRNSNotice of AGM
18th Apr 20244:21 pmRNSDirector/PDMR Shareholding
5th Apr 20242:17 pmRNSNotice of Results
2nd Apr 202411:12 amRNSIssue of equity and total voting rights
28th Mar 20245:55 pmRNSDirector/PDMR Shareholding
28th Mar 20245:47 pmRNSDirector/PDMR Shareholding
28th Mar 20245:42 pmRNSDirector/PDMR Shareholding
28th Mar 20245:26 pmRNSTransaction in Own Shares
27th Mar 20245:23 pmRNSTransaction in Own Shares
26th Mar 20245:05 pmRNSTransaction in Own Shares
26th Mar 20249:09 amRNSDirector/PDMR Shareholding
25th Mar 20245:10 pmRNSTransaction in Own Shares
22nd Mar 20245:27 pmRNSTransaction in Own Shares - Replacement
22nd Mar 20245:05 pmRNSTransaction in Own Shares
21st Mar 20245:40 pmRNSTransaction in Own Shares
20th Mar 20245:33 pmRNSTransaction in Own Shares
19th Mar 20245:20 pmRNSTransaction in Own Shares
19th Mar 20241:19 pmRNSDirector/PDMR Shareholding
18th Mar 20245:20 pmRNSTransaction in Own Shares
15th Mar 20246:25 pmRNSTransaction in Own Shares
15th Mar 20245:58 pmRNSAnnual Financial Report
14th Mar 20245:30 pmRNSTransaction in Own Shares
14th Mar 20243:04 pmRNSDirector/PDMR Shareholding
14th Mar 20242:56 pmRNSDirector/PDMR Shareholding
13th Mar 20245:20 pmRNSTransaction in Own Shares
12th Mar 20245:15 pmRNSTransaction in Own Shares
11th Mar 20245:50 pmRNSTransaction in Own Shares
8th Mar 20245:45 pmRNSTransaction in Own Shares
7th Mar 20245:20 pmRNSTransaction in Own Shares
6th Mar 20245:10 pmRNSTransaction in Own Shares
5th Mar 20245:15 pmRNSTransaction in Own Shares
4th Mar 20245:55 pmRNSTransaction in Own Shares
1st Mar 20245:15 pmRNSTransaction in Own Shares
1st Mar 20249:25 amRNSIssue of Equity and total voting rights
29th Feb 20245:25 pmRNSTransaction in Own Shares
29th Feb 20243:10 pmRNSDirector/PDMR Shareholding
29th Feb 20243:00 pmRNSDirector/PDMR Shareholding
29th Feb 20242:53 pmRNSDirector/PDMR Shareholding
28th Feb 20245:25 pmRNSTransaction in Own Shares
27th Feb 20245:35 pmRNSTransaction in Own Shares
26th Feb 20245:35 pmRNSTransaction in Own Shares
26th Feb 20241:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.